JPMorgan cuts target for Solvay stock to EUR 28.50

Published on 10/26/2026 at 17:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EBITDA reached EUR 173.00 million in the third quarter. Solvay stock costs EUR 23.49 on October 26, 2026, 0.47 percent below the Frankfurt close.

JPMorgan target revised

JPMorgan lowered its Solvay target from EUR 30.00 to EUR 28.50 on October 20, 2026.
Solvay reported third-quarter underlying EBITDA of EUR 173.00 million and net sales of EUR 1.03 billion on October 19, 2026.
Solvay stock costs EUR 23.49 at Lang & Schwarz on October 26, 2026 at 4:59 p.m. CET, 0.47 percent below the Frankfurt close of October 23, 2026.
Solvay will publish final third-quarter 2026 results on November 4, 2026.

Solvay, BE0003470755, Illustration mit AI erstellt.

JPMorgan lowered its Solvay target from EUR 30.00 to EUR 28.50 on October 20, 2026, while maintaining its Overweight rating, according to Zonebourse. The revised target stood 21.33 percent above the EUR 23.49 Solvay stock price. At Lang & Schwarz on October 26, 2026 at 4:59 p.m. CET, the stock was trading at EUR 23.49, down 0.47 percent versus the Frankfurt close of October 23, 2026 at EUR 23.60.

Third-quarter results reset guidance

Solvay reported preliminary third-quarter underlying net sales of EUR 1.03 billion, underlying EBITDA of EUR 173.00 million and free cash flow to shareholders from continuing operations of EUR 54.00 million on October 19, 2026. The figures came with a revised full-year outlook, as the company now expects underlying EBITDA of EUR 720.00 million to EUR 740.00 million, compared with its previous range of EUR 770.00 million to EUR 850.00 million, according to Solvay.

Stock sits above yearly low

The EUR 23.49 quote was 4.03 percent above the 52-week low of EUR 22.58 and 19.44 percent below the 52-week high of EUR 29.16. The range and the EUR 2.4 billion market capitalization were reported as of October 23, 2026, while trading volume on Euronext Brussels reached 304,810 shares.

Valuation and reporting date

JPMorgan's revised EUR 28.50 target gives the stock a measurable recovery threshold, but it remains below the EUR 30.00 level cited in the earlier recommendation. Solvay's next scheduled event is the publication of final third-quarter 2026 results on November 4, 2026, a date listed in the company's investor information and its market profile.

Operational pressure remains visible

Solvay said the Middle East conflict reduced underlying EBITDA by EUR 25.00 million in the third quarter, including EUR 15.00 million linked to the shutdown of the peroxide plant at the Sadara complex in Jubail, Saudi Arabia. The company also reduced its full-year free cash flow outlook to EUR 120.00 million to EUR 150.00 million, from at least EUR 200.00 million previously.

Stock position before November results

The current quotation leaves Solvay above its yearly low but below both the latest JPMorgan target and the previous target level. For investors, the November 4 results will provide the next dated test of the revised EBITDA range and the cash flow outlook.

Solvay stock was trading at EUR 23.49 at Lang & Schwarz on October 26, 2026 at 4:59 p.m. CET, down 0.47 percent versus the Frankfurt close of October 23, 2026 at EUR 23.60. The further course of trading is shown by the continuously updated real-time quote of Solvay stock.